NCT07264569
- Conditions
- Central Nervous System Neoplasms, Meningeal Carcinomatosis, Meningeal Metastasis, +5 more
- Locations
-
- Phase Ib/II Clinical Study to Evaluate the Safety, Tolerability, Biodistribution Characteristics and Preliminary Efficacy of Recombinant Human nsIL12 Oncolytic Adenovirus Injection (BioTTT001) in the Treatment of Patients With Recurrent/Progressive Non-s Zhengzhou, Henan, China